Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 936130-82-4 | MDL No. : | MFCD02179141 |
Formula : | C13H18ClNO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | RBOHZKFJKGYRPA-UHFFFAOYSA-N |
M.W : | 255.74 | Pubchem ID : | 42614593 |
Synonyms : |
|
Num. heavy atoms : | 17 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.46 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 73.48 |
TPSA : | 38.33 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.55 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 3.25 |
Log Po/w (WLOGP) : | 2.36 |
Log Po/w (MLOGP) : | 2.39 |
Log Po/w (SILICOS-IT) : | 2.58 |
Consensus Log Po/w : | 2.12 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.54 |
Solubility : | 0.0744 mg/ml ; 0.000291 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.73 |
Solubility : | 0.0478 mg/ml ; 0.000187 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.69 |
Solubility : | 0.0522 mg/ml ; 0.000204 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 1.53 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 149353-84-4 ]
4-(Piperidin-4-yl)benzoic acid hydrochloride
Similarity: 0.90
[ 1220021-56-6 ]
Piperidin-4-ylmethyl benzoate hydrochloride
Similarity: 0.89
[ 1391547-09-3 ]
(S)-Methyl 4-(piperidin-2-yl)benzoate hydrochloride
Similarity: 0.85
[ 51352-87-5 ]
Methyl 3-(2-(benzyl(methyl)amino)ethyl)benzoate hydrochloride
Similarity: 0.84
[ 1046758-68-2 ]
Methyl 2-(2-aminoethyl)benzoate hydrochloride
Similarity: 0.84
[ 1220021-56-6 ]
Piperidin-4-ylmethyl benzoate hydrochloride
Similarity: 0.89
[ 220247-69-8 ]
Methyl 1,2,3,4-tetrahydroisoquinoline-7-carboxylate hydrochloride
Similarity: 0.86
[ 1391547-09-3 ]
(S)-Methyl 4-(piperidin-2-yl)benzoate hydrochloride
Similarity: 0.85
[ 51352-87-5 ]
Methyl 3-(2-(benzyl(methyl)amino)ethyl)benzoate hydrochloride
Similarity: 0.84
[ 1046758-68-2 ]
Methyl 2-(2-aminoethyl)benzoate hydrochloride
Similarity: 0.84
[ 149353-84-4 ]
4-(Piperidin-4-yl)benzoic acid hydrochloride
Similarity: 0.90
[ 1220021-56-6 ]
Piperidin-4-ylmethyl benzoate hydrochloride
Similarity: 0.89
[ 1391547-09-3 ]
(S)-Methyl 4-(piperidin-2-yl)benzoate hydrochloride
Similarity: 0.85
[ 37663-46-0 ]
3H-Spiro[isobenzofuran-1,4'-piperidin]-3-one
Similarity: 0.84
[ 455323-66-7 ]
Methyl 4-(piperidin-4-yloxy)benzoate hydrochloride
Similarity: 0.79